In Vitro Bioequivalence Studies of Topical Drug Products: Challenges and Promises of IVRT and IVPT 

Hiren Patel from the Office of Generic Drugs discusses In Vitro Bioequivalence Studies of Topical Drug Products: Challenges and Promises of In Vitro Release Test (IVRT) and In Vitro Permeation Test (IVPT).
Patel highlights issues observed with IVRT and IVPT studies submitted in ANDAs to support bioequivalence of topical drug products. Patel discusses scientific challenges related to the development and validation of IVRT and IVPT methods along with data analysis. Practical considerations for the submission of detailed and well-organized information in ANDAs will be described.
Learn more at www.fda.gov/dr...
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming Training - www.fda.gov/cd...
SBIA Listserv - public.govdeli...
SBIA 2020 Playlist - • 2020 CDER Small Busine...
SBIA LinkedIn - / cder-small-business-an...
SBIA Training Resources - www.fda.gov/cd...
Twitter - / fda_drug_info
Email - CDERSBIA@fda.hhs.gov
Phone - (301) 796-6707 I (866) 405-5367